Flex Pharma, Inc., a biotechnology company, develops and commercializes products for the treatment of nocturnal leg cramps, muscle cramps, spasms, and spasticity associated with neuromuscular conditions; and exercise-associated muscle cramps. The company develops its products based on the mechanism of muscle cramp inhibition. Flex Pharma, Inc. was founded in 2014 and is headquartered in Boston, Massachusetts.
